deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT03751449

Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors

Exercise and Nutrition Intervention in Older Breast Cancer Survivors - The WIN CA Study

Sponsor: Roswell Park Cancer Institute

Conditions Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage IA Breast Cancer AJCC v8 Anatomic Stage IB Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIA Breast Cancer AJCC v8 Anatomic Stage IIB Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 Anatomic Stage IIIC Breast Cancer AJCC v8 Cancer Survivor Inactivity Obesity Overweight Prognostic Stage I Breast Cancer AJCC v8 Prognostic Stage IA Breast Cancer AJCC v8 Prognostic Stage IB Breast Cancer AJCC v8 Prognostic Stage II Breast Cancer AJCC v8 Prognostic Stage IIA Breast Cancer AJCC v8 Prognostic Stage IIB Breast Cancer AJCC v8 Prognostic Stage III Breast Cancer AJCC v8 Prognostic Stage IIIA Breast Cancer AJCC v8 Prognostic Stage IIIB Breast Cancer AJCC v8 Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions Educational Intervention Exercise Intervention Quality-of-Life Assessment Questionnaire Administration
Updated 14 times since 2018 Last updated: Jun 3, 2022 Started: Mar 25, 2019 Primary completion: May 1, 2021 Completion: May 21, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of resources

Other terminated trials from Roswell Park Cancer Institute

See all terminations from Roswell Park Cancer Institute

Other Anatomic Stage I Breast Cancer AJCC v8 trials with similar outcome

Browse all Anatomic Stage I Breast Cancer AJCC v8 trials

This NA trial investigates Anatomic Stage I Breast Cancer AJCC v8 and Anatomic Stage IA Breast Cancer AJCC v8 and is currently terminated or withdrawn. Roswell Park Cancer Institute leads this study, which shows 14 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2018 – ~Jul 2019 · 7 months · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Mar 2020 · 6 months · monthly snapshot~Mar 2020 – ~Sep 2020 · 6 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Apr 2022 · 59 days · monthly snapshot~Apr 2022 – ~Jul 2022 · 3 months · monthly snapshot~Jul 2022 – ~Jul 2024 · 24 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jul 2022 — Jul 2024 [monthly]

    Terminated NA

    Status: Suspended → Terminated

  4. Apr 2022 — Jul 2022 [monthly]

    Suspended NA

  5. Feb 2022 — Apr 2022 [monthly]

    Suspended NA

▶ Show 9 earlier versions

  1. Sep 2021 — Feb 2022 [monthly]

    Suspended NA

    Status: Recruiting → Suspended

  2. Apr 2021 — Sep 2021 [monthly]

    Recruiting NA

  3. Jan 2021 — Apr 2021 [monthly]

    Recruiting NA

  4. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

  5. Mar 2020 — Sep 2020 [monthly]

    Recruiting NA

  6. Sep 2019 — Mar 2020 [monthly]

    Recruiting NA

  7. Aug 2019 — Sep 2019 [monthly]

    Recruiting NA

  8. Jul 2019 — Aug 2019 [monthly]

    Recruiting NA

  9. Dec 2018 — Jul 2019 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Roswell Park Cancer Institute
Data source: Roswell Park Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations